Literature DB >> 22546411

Functional role of muscarinic receptor subtypes in calcium sensitization and their contribution to rho-kinase and protein kinase C pathways in contraction of human detrusor smooth muscle.

Nouval Shahab1, Shunichi Kajioka, Narihito Seki, Seiji Naito.   

Abstract

OBJECTIVE: We investigated the role of muscarinic receptor subtypes in calcium sensitization and their contribution to rho-kinase (ROK) and protein kinase C (PKC) pathways in carbachol (CCh)-induced contraction of human detrusor smooth muscle (DSM).
MATERIALS AND METHODS: α-toxin-permeabilized human DSM strips were prepared and mounted horizontally to record isometric force. The roles of M(2) and M(3) muscarinic receptors in Ca(2+) sensitization were studied using selective antagonists of M(2) (AF-DX116) and M(3) (4-DAMP) receptor subtypes. The effects of a selective inhibitor of ROK, Y-27632, and a selective inhibitor of PKC, bisindolylmaleimide I (GF-109203X), were also studied on contraction induced by 10 μM CCh with 100 μM guanosine triphosphate at a fixed 1 μM [Ca(2+)](i) after preincubation with 1 μM AF-DX116 or 1 μM 4-DAMP.
RESULTS: Carbachol-induced Ca(2+) sensitization was predominantly inhibited by 4-DAMP compared with AF-DX116. Four-DAMP equivalently inhibited the relaxation effect of 5 μM GF-109203X as well as that of 5 μM Y-27632 on CCh-induced Ca(2+) sensitization. AF-DX116 reduced the relaxation effect of Y-27632 to a greater degree than GF-109203X.
CONCLUSION: The results of the present study have demonstrated the predominant role of M(3) receptor subtype in Ca(2+) sensitization and the relative contribution to ROK and PKC pathways. Our study also shows that the ROK pathway is dominant compared with the PKC pathway after M(2) receptor activation, which in turn is inferior, but not negligible, in producing Ca(2+) sensitization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546411     DOI: 10.1016/j.urology.2011.11.047

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  BK channel-mediated relaxation of urinary bladder smooth muscle: a novel paradigm for phosphodiesterase type 4 regulation of bladder function.

Authors:  Wenkuan Xin; Ning Li; Qiuping Cheng; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2014-01-23       Impact factor: 4.030

Review 2.  Drugs Currently Undergoing Preclinical or Clinical Trials for the Treatment of Overactive Bladder: A Review.

Authors:  Silvia Joseph; Steffi A Maria; Jacob Peedicayil
Journal:  Curr Ther Res Clin Exp       Date:  2022-04-06

3.  Post-Irradiation Bladder Syndrome After Radiotherapy of Malignant Neoplasm of Small Pelvis Organs: An Observational, Non-Interventional Clinical Study Assessing VESIcare®/Solifenacin Treatment Results.

Authors:  Janusz Jaszczyński; Zbigniew Kojs; Andrzej Stelmach; Łukasz Wohadło; Elzbieta Łuczyńska; Sylwia Heinze; Janusz Rys; Jerzy Jakubowicz; Piotr Chłosta
Journal:  Med Sci Monit       Date:  2016-07-30

4.  Functional and molecular changes of the bladder in rats with crushing injury of nerve bundles from major pelvic ganglion to the bladder: role of RhoA/Rho kinase pathway.

Authors:  Su Jin Kim; Dong Sup Lee; Woong Jin Bae; Seol Kim; Sung Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Sae Woong Kim
Journal:  Int J Mol Sci       Date:  2013-08-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.